Cargando…
The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM)
BACKGROUND: Finger prick blood glucose (BG) monitoring remains a mainstay of management in people with type 2 diabetes (T2DM) who take sulphonylurea (SU) drugs or insulin. We recently examined patient experience of BG monitoring in people with type 1 diabetes (T1DM). There has not been any recent co...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917860/ https://www.ncbi.nlm.nih.gov/pubmed/34921531 http://dx.doi.org/10.1002/edm2.302 |
_version_ | 1784668637403021312 |
---|---|
author | Stedman, Mike Rea, Rustam Duff, Christopher J. Livingston, Mark McLoughlin, Katie Wong, Louise Brown, Stephen Grady, Katherine Gadsby, Roger Gibson, John M. Paisley, Angela Fryer, Anthony A. Heald, Adrian H. |
author_facet | Stedman, Mike Rea, Rustam Duff, Christopher J. Livingston, Mark McLoughlin, Katie Wong, Louise Brown, Stephen Grady, Katherine Gadsby, Roger Gibson, John M. Paisley, Angela Fryer, Anthony A. Heald, Adrian H. |
author_sort | Stedman, Mike |
collection | PubMed |
description | BACKGROUND: Finger prick blood glucose (BG) monitoring remains a mainstay of management in people with type 2 diabetes (T2DM) who take sulphonylurea (SU) drugs or insulin. We recently examined patient experience of BG monitoring in people with type 1 diabetes (T1DM). There has not been any recent comprehensive assessment of the performance of BG monitoring strips or the patient experience of BG strips in people with T2DM in the UK. METHODS: An online self‐reported questionnaire containing 44 questions, prepared following consultation with clinicians and patients, was circulated to people with T2DM. 186 responders provided completed responses (25.5% return rate). Fixed responses were coded numerically (eg not confident = 0 fairly confident = 1). RESULTS: Of responders, 84% were treated with insulin in addition to other agents. 75% reported having had an HbA1c check in the previous 6 months. For those with reported HbA1c ≥ 65 mmol/mol, a majority of people (70%) were concerned or really concerned about the shorter term consequences of running a high HbA1c This contrasted with those who did not know their recent HbA1c, of whom only 33% were concerned/really concerned and those with HbA1c <65 mmol/mol of whom 35% were concerned. Regarding BG monitoring/insulin adjustment, only 25% of responders reported having sufficient information with 13% believing that the accuracy and precision of their BG metre was being independently checked. Only 9% recalled discussing BG metre accuracy when their latest metre was provided and only 7% were aware of the International Standardisation Organisation (ISO) standards for BG metres. 77% did not recall discussing BG metre performance with a healthcare professional. CONCLUSION: The group surveyed comprised engaged people with T2DM but even within this group there was significant variation in (a) awareness of shorter term risks, (b) confidence in their ability to implement appropriate insulin dosage (c) awareness of the limitations of BG monitoring technology. There is clearly an area where changes in education/support would benefit many. |
format | Online Article Text |
id | pubmed-8917860 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89178602022-03-18 The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM) Stedman, Mike Rea, Rustam Duff, Christopher J. Livingston, Mark McLoughlin, Katie Wong, Louise Brown, Stephen Grady, Katherine Gadsby, Roger Gibson, John M. Paisley, Angela Fryer, Anthony A. Heald, Adrian H. Endocrinol Diabetes Metab Original Research Article BACKGROUND: Finger prick blood glucose (BG) monitoring remains a mainstay of management in people with type 2 diabetes (T2DM) who take sulphonylurea (SU) drugs or insulin. We recently examined patient experience of BG monitoring in people with type 1 diabetes (T1DM). There has not been any recent comprehensive assessment of the performance of BG monitoring strips or the patient experience of BG strips in people with T2DM in the UK. METHODS: An online self‐reported questionnaire containing 44 questions, prepared following consultation with clinicians and patients, was circulated to people with T2DM. 186 responders provided completed responses (25.5% return rate). Fixed responses were coded numerically (eg not confident = 0 fairly confident = 1). RESULTS: Of responders, 84% were treated with insulin in addition to other agents. 75% reported having had an HbA1c check in the previous 6 months. For those with reported HbA1c ≥ 65 mmol/mol, a majority of people (70%) were concerned or really concerned about the shorter term consequences of running a high HbA1c This contrasted with those who did not know their recent HbA1c, of whom only 33% were concerned/really concerned and those with HbA1c <65 mmol/mol of whom 35% were concerned. Regarding BG monitoring/insulin adjustment, only 25% of responders reported having sufficient information with 13% believing that the accuracy and precision of their BG metre was being independently checked. Only 9% recalled discussing BG metre accuracy when their latest metre was provided and only 7% were aware of the International Standardisation Organisation (ISO) standards for BG metres. 77% did not recall discussing BG metre performance with a healthcare professional. CONCLUSION: The group surveyed comprised engaged people with T2DM but even within this group there was significant variation in (a) awareness of shorter term risks, (b) confidence in their ability to implement appropriate insulin dosage (c) awareness of the limitations of BG monitoring technology. There is clearly an area where changes in education/support would benefit many. John Wiley and Sons Inc. 2021-12-17 /pmc/articles/PMC8917860/ /pubmed/34921531 http://dx.doi.org/10.1002/edm2.302 Text en © 2021 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Article Stedman, Mike Rea, Rustam Duff, Christopher J. Livingston, Mark McLoughlin, Katie Wong, Louise Brown, Stephen Grady, Katherine Gadsby, Roger Gibson, John M. Paisley, Angela Fryer, Anthony A. Heald, Adrian H. The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM) |
title | The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM) |
title_full | The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM) |
title_fullStr | The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM) |
title_full_unstemmed | The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM) |
title_short | The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM) |
title_sort | experience of blood glucose monitoring in people with type 2 diabetes mellitus (t2dm) |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917860/ https://www.ncbi.nlm.nih.gov/pubmed/34921531 http://dx.doi.org/10.1002/edm2.302 |
work_keys_str_mv | AT stedmanmike theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT rearustam theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT duffchristopherj theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT livingstonmark theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT mcloughlinkatie theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT wonglouise theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT brownstephen theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT gradykatherine theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT gadsbyroger theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT gibsonjohnm theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT paisleyangela theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT fryeranthonya theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT healdadrianh theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT stedmanmike experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT rearustam experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT duffchristopherj experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT livingstonmark experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT mcloughlinkatie experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT wonglouise experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT brownstephen experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT gradykatherine experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT gadsbyroger experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT gibsonjohnm experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT paisleyangela experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT fryeranthonya experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm AT healdadrianh experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm |